Risk perception and vulnerabilities for HIV/AIDS among transgender women in Brazil: mixed methods approach.
Paulie Marcelly Ribeiro Dos SantosKamilla Cardoso Dos SantosBrunna Rodrigues de OliveiraLarissa Silva MagalhãesKarlla Antonieta Amorim CaetanoVanessa da Silva Carvalho VilaLeonora Rezende PachecoMegmar Aparecida Dos Santos CarneiroSonia Maria Ferreira DiasJeanne-Marie SttaciariniSheila Araujo TelesPublished in: AIDS care (2022)
Transgender women (TW) are a key population in the dynamics of human immunodeficiency virus (HIV) dissemination, although little is known about their perceptions of HIV risk. In this embedded, nested, mixed-methods study, we assessed factors associated with condomless sexual intercourse among TW and explored their risk perceptions and vulnerabilities regarding HIV exposure. The first phase involved a cross-sectional study, followed by qualitative interviews. Condomless sexual intercourse during their last sexual encounter was reported by 37.3% of participants, and 16.1% previously tested positive for HIV. Age older than 21 years, single status, and being a sex worker were protective factors for condomless intercourse. Otherwise, TW who reported a past sexual partner with a known sexually transmitted infection and those aware of post-exposure prophylaxis had a greater risk of condomless sexual intercourse ( p < 0.05) during their most recent encounter. The qualitative interviews revealed that, despite TW being aware of their risk of contracting HIV, their vulnerabilities overlapped their risk perception, making them trivialize or ignore the risk. This study will help to understand the HIV dynamics among TW and contribute to further health research, education, policymaking, and planning associated with specific health strategies to promote the sexual health of TW.
Keyphrases
- men who have sex with men
- hiv testing
- hiv positive
- human immunodeficiency virus
- antiretroviral therapy
- hiv aids
- hiv infected
- hepatitis c virus
- healthcare
- mental health
- primary care
- south africa
- randomized controlled trial
- study protocol
- polycystic ovary syndrome
- clinical trial
- breast cancer risk
- single cell
- quality improvement
- pregnancy outcomes